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A Sendai virus expression vector in the form of a transcribing copy-back defective interfering RNA was constructed and
shown to efficiently express a tagged matrix protein in the only context of a Sendai virus infection. In an attempt to identify
relevant M protein domains involved in viral assembly and budding, a series of deletion mutants were tested for their ability
to bind to cellular membrane fractions. The deletion of a region spanning amino acids 105–137 significantly decreased this
binding when the protein was expressed in a system driven by the T7 RNA polymerase away from any other viral proteins.
Plus or minus charges were introduced in the hydrophobic portion of a predicted amphiphilic helix in this region, and M
proteins with altered membrane binding properties were produced. The genes encoding these mutant M proteins were
then inserted in the Sendai virus vector and shown to be expressed at levels similar to that of the endogenous wild-type
M protein. The presence of a negative charge in the hydrophobic region of the putative amphiphilic helix prevented the
incorporation of the mutant protein into virus particles and appeared to decrease the efficiency of virus particle budding.
In contrast, the introduction of a positive charge appeared to increase the M mutant uptake into virions. The use a Sendai
virus vector has therefore been shown instrumental in the identification of mutant M proteins interfering with the viral
assembly-budding process. q 1996 Academic Press, Inc.
INTRODUCTION this latter being identical to the nondefective (ND) plus
strand RNA 3* end. On the other hand, E307-RNA (1794
The study of negative-stranded RNA viruses reached
nucleotides) is an internal deletion defective RNA, with
a turning point when it became possible to replicate,
conservation of the ND viral RNA 3* and 5* ends (Calain
initially, viral ‘‘mini-genomes’’ (Grosfeld et al., 1995; Yu et
and Roux, 1995, 1993). The minus strand 3* end of theal., 1995; Pattnaik et al., 1995; Calain and Roux, 1995;
ND RNA contains, in cis, the recognition site for the RNAWertz et al., 1994; Conzelmann and Schnell, 1994; Di-
polymerase to bind and initiate RNA synthesis, as wellmock and Collins, 1993; Calain and Roux, 1993; Pattnaik
as the signal for the initiation of N gene mRNA synthesis.et al., 1992; Calain et al., 1992; Collins et al., 1991; Park
It is also the template for the leader/ RNA onto whichet al., 1991; Stillman et al., 1995), and more recently, full-
the encapsidation initiation takes place in the processlength genomes (Garcin et al., 1995; Radecke et al., 1995;
of antigenome replication (Vidal and Kolakofsky, 1989;Whelan et al., 1995; Lawson et al., 1995; Conzelmann
Kolakofsky and Blumberg, 1982; Kingsbury, 1974). Thisand Schnell, 1994), from cloned cDNAs. This opened,
important regulation region, still ill-defined in its primaryat last, the ability to apply site-directed mutagenesis to
structure and in its length, will be called hereafter fordescribe and understand the viral functions. The manipu-
convenience the genomic promoter (GP). On the otherlation of full-length cDNA clones (containing ten to fifteen
hand, the plus strand ND RNA 3* end, called hereafter thethousands of nucleotides), however, remains tedious. In
antigenomic promoter (AGP), is devoted to only genomiccontrast, cDNA clones derived from subgenomic viral
RNA replication and is lacking the signal for mRNA syn-RNAs, as natural or artificial defective RNAs, are consid-
thesis. Therefore, H4-RNA, with an antigenomic promotererably more amenable to manipulation. Two natural Sen-
on both strand 3* ends, does not produce mRNAs, indai virus (SeV) defective RNAs (H4 and E307-RNAs) were
contrast to E307-RNA (for a schematic representation ofcloned and successfully replicated from plasmids in a
these RNAs see Fig. 1).transfected cell system. H4-RNA (1410 nucleotides) has
Previous work, using these defective RNAs demon-the classical features of a copy back defective interfering
strated that only RNAs whose total nucleotide number wasRNA, where the minus strand RNA 3* end is an exact
a multiple of six were efficiently replicated. This basic fea-copy of the plus strand RNA 3* end over 110 nucleotides,
ture of Sendai virus replication was termed the ‘‘rule of six’’
(Calain and Roux, 1995, 1993). Through reciprocal substitu-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 41.22. 702.5702. E-mail: Roux@cmu.unige.ch. tions between the GP and AGP regions of the H4 and E307-
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RNAs, the conclusion was further drawn that the replication the viral glycoprotein (Sanderson et al., 1994, 1993). This
illustrates how little one knows about the function of thisefficiency was somehow tied to the primary sequence. For
instance, the substitution of the first 48 nucleotides of the viral protein considered as essential for virus assembly
and budding. Other basic questions like the minimumE307 genomic promoter with those of the antigenomic pro-
moter was sufficient to increase the replication efficiency requirements for viral particle budding as well as the
temporal order and the cellular location of the variousof E307-RNA by 20-fold. This new RNA, called E307-GP48
RNA (to indicate that 48 nucleotides of GP had been re- steps postulated in viral assembly have not yet received
definitive answers.placed by the correspondent nucleotides coming from
AGP), was also supporting transcription, although at a lower Using the recent advance in reverse genetics, we de-
scribe here the construction of a SeV vector capable oflevel than E307-RNA. Interestingly, the efficiency of tran-
scription appeared affected by the extent of the antigeno- high and stable replication in a SeV-mixed virus stock.
This vector was further used to express a tagged viral Mmic sequence substitution, since a construct with a 42
nucleotide substitution (E307-GP42 RNA) exhibited a higher protein in the only context of the SeV infection. Mutations
introduced in this tagged protein produced M proteinstranscription ability than E307-GP48 RNA (for a more exten-
sive description see Calain and Roux, 1995). interfering with virus particle assembly and budding.
SeV is an enveloped virus: The viral membrane is de-
rived from the cellular plasma membrane where the viral MATERIALS AND METHODS
components are believed to assemble before budding.
Viruses and cellsViral assembly is generally viewed as organized by the
matrix protein M, which, soon after synthesis in the cyto- Hela and BHK-21 cells were grown in regular MEM
plasm, forms a layer at the inner side of the plasma supplemented with 5% fetal calf serum under 5% CO2
membrane. These patches of M, would then favor the atmosphere. Nondefective (ND) Sendai virus (SeV) Harris
gathering of two viral transmembrane glycoproteins HN strain was prepared and characterized as before (Roux
and F0, with the exclusion of the cellular proteins. The and Holland, 1979). The SeV stocks containing the defec-
viral nucleocapsids, with the RNA polymerase attached, tive RNAs generated from plasmids (SeV mixed virus
would finally join the virally modified plasma membrane, stocks) are described in a separate section. Vaccinia
completing the viral assembly in a structure that can be recombinant virus expressing the T7 RNA polymerase,
seen as ‘‘prebudding.’’ The stability of this ‘‘prebudding vTF7-3, a gift from Bernard Moss (National Institutes of
structure’’ was then proposed to be critical for the forma- Health, Bethesda, MD), has been described by Fuerst
tion of a bud which pinches off in the extracellular me- and colleagues (1986) and used accordingly. vTF7-3
dium (Tuffereau and Roux, 1988). To fulfill its central role stocks were grown in Hela cells with titers ranging from
in viral assembly, the M protein is therefore expected, 5 108 to 109 PFU/ml.
and has been shown, by cross-linking, electron micro-
scopic and biophysical studies to interact with itself, with Sequence and plasmids
the plasma membrane, with the viral glycoproteins, with
the nucleocapsid and with components of the cytoskele- The complete SeV RNA primary sequence (15,384 nu-
cleotides) is taken from Shioda et al. (1986) with theton. (for reviews on Paramyxovirus assembly and bud-
ding, see Ray et al., 1991; Peeples, 1991). Despite a large correction by Neubert et al. (1991). The convention used
for numbering the SeV genomes starts at the 3* end ofbody of information, no data have been reported so far
that would characterize these multiple interactions at the the minus strand RNA or at the 5* end of the plus strand
RNA, consistent with the gene expression. The plasmidsmolecular level.
SeV M protein contains 348 amino acids and has a expressing the SeV N, P, and L proteins (respectively,
pGem-N, pGem-P/Cstop, and pGem-L) under the controlmolecular weight of 38 kDa. With an isoelectric point
higher than 10, the protein is positively charged at neutral of the T7 RNA polymerase have been described pre-
viously (Kast et al., 1991; Curran et al., 1991).pH. A fraction of the protein is phosphorylated on serine
residues (Lamb and Choppin, 1977), and the reactivity The cloning of the natural SeV copy back (H4) and
internal deletion (E307) DI RNAs in pSP65 under the con-with monoclonal antibodies recognise two distinct iso-
forms (de Melo et al., 1992), unrelated to the degree trol of the T7 RNA polymerase promoter is described in,
respectively, Calain et al. (1992) and Engelhorn et al.of phosphorylation. Although two myristylation sites are
predicted (PSIGNAL, PCGENE, Intellegenetics Inc.), no (1993). The addition of a ribozyme at the 3* end of the
viral sequence to produce, upon T7 RNA polymerasefatty acid addition could be demonstrated (Veit et al.,
1989). Fifty percent of SeV M synthesized from recombi- transcription, an exact copy of the natural DI RNAs, as
positive strand, has been described in detail in Calainnant plasmid has been shown to specifically associate
by itself with cellular membrane fractions (Stricker et al., and Roux (1995).
The series of plasmids carrying the sequences derived1994). Other data, however, suggested that this interac-
tion only takes place in the presence of, at least, one of from E307 RNA presented in Fig. 1 were cloned by stan-
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dard methods, using oligonucleotides and PCR fusion fection, the intracellular nucleocapsids were purified and
the nucleocapsid RNAs analyzed by Northern blots.products when needed. The extra sequence of the
multicloning site (MCS) inserted in E307 at the BspMI
M protein deletion and point mutantssite or at nucleotide 119 (see Fig. 1) was: 3*-GGACUU-
CGAACUCGAGAGCUCGACGUCCUAGGCUUAAGC-5* Using convenient restriction sites, the M protein gene
sequence in M-pGem4 (de Melo et al., 1992) was modi-(as minus strand) with the extra nucleotides G, GU, GUC,
GUCA, or GUCAG added at the 5* end to create the fied by conventional cloning methods. Excision of internal
fragments, insertion of adequate oligonucleotides to re-series of sequences to comply to the rule of six (see text
of Results). This MCS contained the HindIII, SalI, XhoI, create the correct reading frame, fill in reactions, or inser-
tion of ad hoc three-way stop codons to create prematurePstI, BamHI, and EcoRI restriction sites. In all the plas-
mids, the viral sequences were flanked by the T7 RNA stops were performed adequately. The point mutations
at residues 112 and 113 were introduced as follows. Anand SP6 (past the ribozyme) polymerase promoters per-
mitting the transcription of RNAs, respectively, of positive oligonucleotide Muthelix1 spanning a StuI site, posi-
tioned at nucleotide 345 ahead of the triplets encoding(T7) and negative (SP6) polarity. To obtain HA-M-pGem4,
an epitope of the influenza virus HA1 (Field et al., 1988) threonine 112 (ACG, nt 366–368) and valine 113 (GTG,
nt 369–371), was built with redundant nucleotides at po-was first inserted, as a double-stranded oligonucleotide
containing a Hha site, into the pGem4 SmaI site to create sition 367 (N) and with an A or a T at position 370 (W)
(Mutehlix1: 5*AAGGCCTGCACCGATCTCAGAATTANA-HA-pGem4. The M gene, excised from M-pGem4 (de
Melo et al., 1992) with HhaI and EcoRI digestions, was NGGWGAGGAGG3*). Muthelix1 was used as a primer in
conjunction with the oligonucleotide Muthelix2 (5*GAA-then inserted into the same sites of HA-pGem4. The ba-
sic vectors were completely sequenced. For the larger AATCAGCCGCATTCTCTCAATCTTGCT3*) spanning a
BsmI site at position 808 to PCR amplify the fragmentconstructions the modified and the critical regions, at the
least, were controlled by extensive sequencing. StuI/BsmI. The PCR products were then inserted in place
of the original M StuI/BsmI fragment, and colonies were
Plasmid transfection and replication system picked and partially sequenced to identify the various
point mutations at the ambiguous positions. Mutants car-
The replication system was designed to replicate the
rying the seven possible insertions were identified re-
viral RNA produced as a T7 RNA polymerase transcript
sulting in five distinct amino acid changes presented in
of positive polarity, containing the exact viral 5* and 3*
Table 2.
ends. The description hereafter contains a few modifica-
tions from the protocol outlined earlier by Calain and Protein analysis
Roux (1995). Hela cells (107) were used (not CV1 cells)
Analyses of the intracellular viral proteins by Western
and infected with vTF7-3 at a m.o.i. of 5 (instead of 3).
blotting were done on an aliquot of the cytoplasmic ex-
The cells were transfected with 2.5 mg of pGem4-N, 2.5
tracts prepared for nucleocapsid RNA analysis (see
mg of pGem4-P/Cstop, 1 mg with pGem4-L, and 5 mg of
above). The virions from the same infections were pel-
the plasmid expressing the RNA template. The nucleo-
leted through a 25% glycerol-TNE cushion for 2 hr at
capsid RNAs were purified and analyzed by Northern
50,000 rpm. Proteins were resolved by SDS–PAGE and
blots as described in details before (Mottet and Roux,
transferred to nitrocellulose membranes as described
1989), using the various probes described in the figure
before (Curran et al., 1991). Filters were incubated with
legends.
an anti M (383) and an anti N (877) monoclonal antibodies
at, respectively, a 1:5,000 and a 1:10,000 dilution or withPreparation of SeV mixed virus stocks
an anti-HA and the anti-N. The blots were developed
with a goat anti-mouse antibody conjugated to alkalineThis method which involves (i) the purification of the
nucleocapsids generated in the replication system de- phosphatase using the chemoluminescent substrate
Lumigen PPD (Boehringer) at a 1:200 dilution. Intracellu-scribed above, (ii) their transfection in BHK cells infected
with ND SeV and (iii) the further injection of these BHK lar protein analysis was also made by immunoprecipita-
tions of 35S-labeled proteins. Samples of 107 BHK cellscells into 9-day-old embryonated chicken eggs to pro-
duce the mixed virus stocks containing the ND and sub- were infected as above and labeled for 2 hr at 337 with
200 mCi of 35S-Trans Label (NEN) in MEM 1/10 the normalgenomic RNAs, was performed exactly as described in
Calain and Roux (1995). The three serial passages in methionine-cysteine plus 0.2% FBS. Cells were then ei-
ther lysed or immunoprecipitated as described in detailseggs of the HA-M-CB119-RNA in these stocks were per-
formed after a 10-fold dilution of the inoculum (100 ml/ before (Mottet et al., 1986).
egg). To analyze the extent of HA-M-CB119-RNA replica-
M protein membrane associationtion, about 107 BHK cells were infected with 1 ml of the
first passage stock undiluted, or 1 ml of the second and About 107 BHK cells were transfected with the pGem4-
M plasmids and infected with vTF7-3 (see above) for 24third passage stocks, diluted 5-fold. Forty hours postin-
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hr. They were then rinsed with PBS and resuspended in a multiple of six (1836) was found to replicate with an
efficiency comparable to that of the parent E307-RNA300 ml of ice-cold 10% (w/w) sucrose containing 10 mM
Tris–HCl, pH 7.5, 1 mM EDTA (TE buffer), 2 mM-PMSF, (not shown, summarized in Table 1), demonstrating that
the introduction of the MCS sequence at that positionand 2% aprotinin. Cells were disrupted by Dounce ho-
mogenization (60 strokes). The cellular extracts were did not prevent replication, at least in the vaccinia virus
system. The extra sequence in the E307-RNA was nextclarified (2 min, 1,000 r.p.m.), adjusted to 80% sucrose,
placed at the bottom of Beckman centrifuge tubes (1.2 removed, by deletion of either the original BspMI–KpnI
(72–15,274) or the BspMI–DraIII (72–15,213) fragmentsparts), and overlaid with 65% sucrose (3 parts), and 10%
sucrose (1 part). After centrifugation (Beckman SW55 ro- to generate, respectively, the SVec-BsKp 0-5 and SVec-
BsDr 0-5 series (Fig. 1). As expected, one RNA from eachtor, 160,000 g, 18 hr, 47), fractions were collected by punc-
turing the bottom of the tubes. series replicated over the background (Fig. 2A, Table 1).
The 5- to 10-fold better replication of SVec-BsDr 0 over
SVec-BsKp 2 was routinely observed. The reason for thatAntibodies
remained unclear since the replacement of the KpnI –
The monoclonal antibodies against the M and N pro- DraIII fragment by an unrelated fragment of the same
teins were a kind gift of Claes O¨rvell (Laboratory of Clini- size coming from the 3* untranslated region of the M
cal Virology, Huddinge Hospital, Huddinge, Sweden) and gene produced the same effect (not shown). The se-
were prepared according to standard procedure. The quence of the SeV matrix gene was next inserted into
anti-HA antibodies (12CA5, (Field et al., 1988) were ob- the MCS of these vectors. To eventually distinguish be-
tained from the Berkeley Antibody Co. The rabbit poly- tween the endogenous and this extra M protein, the latter
clonal sera raised against the whole virus (RAb-vir) and was tagged with an influenza HA epitope (HA-M). The
the SDS-denatured M protein(MSDS) have been described replication efficiency of the legitimate (i.e., obeying the
before (respectively, Mottet et al., 1986, and Tuffereau rule of six) RNA of both series was more than 10-fold
and Roux, 1988). lower than that of the E307 and E307-MCS RNAs (Table
1, HA-M-BsDr and HA-M-BsKp) and repeated attempts
RESULTS to produce SeV-mixed virus stocks containing HA-M-
BsKp or HA-M-BsDr RNA genomes failed (not shown).Construction of Sendai virus vector
As it was known from previous experiments (unpublished
results and Calain and Roux, 1995), that the replicationIn a previous work, the SeV natural internal deletion
DI-RNA E307, cloned into the plasmid pSVE307, was efficiency of the plasmid-derived E307-RNA was at the
lowest limit which permitted its successful introductionshown to successfully replicate when expressed by the
T7 RNA polymerase, in a system where the viral functions into a mixed virus stock, this was not surprising. The
loss of efficient replication correlated with the insertionL, P, and N needed for replication were also provided in
trans by T7 transcription of appropriate plasmids (Calain of the HA-M gene, suggesting that some feature of this
sequence was detrimental in the context. Also, the in-and Roux, 1995). The plasmid produced E307 genome
was further introduced into a SeV-mixed virus stock crease in the RNA size consecutive to this insertion could
have added new constraints, which were not apparentwhere it was shown to express the protein it was coding
for (i.e., the truncated form of N), with the same efficiency in the replication of the basic vectors. Since the reason
for the poor replication of these RNAs was unclear, andas that of the original natural SeV-mixed virus stock it
was originating from. therefore not easy to circumvent, we decided to try and
empirically increase the replication efficiency as outlinedStarting from the plasmid pSV-E307, containing the
E307 RNA sequence, a multicloning site (MCS) was first below.
First, as the promoter required for optimal replicationinserted at a convenient BspMI site in the untranslated
region of the N gene, at nucleotide 72 (Fig. 1, also see is yet poorly defined, we extended the 3* end of RNA to
nucleotide 119, i.e., to the nucleotide preceding the NMethods for the convention of numbering the SeV ge-
nomes). These 72 nucleotides include the 3* end se- gene AUG to create Svec 119. This novel 3* end now
included the hypothetical BB3 box proposed to be partquence previously shown to allow replication of and tran-
scription from a DI-RNA derivative (AGP65-RNA; Calain of the promoter (nucleotide 75–90; Blumberg et al., 1991;
Crowley et al., 1988). Second, Svec 119 was turned intoand Roux, 1995). To be able to construct future vectors
containing extra genes of possibly unknown or imprecise a copy back RNA by replacing the first 48 nucleotides of
its negative-strand 3* end (genomic promoter) with thenucleotide number, six MCS differing by one nucleotide
were designed, so that one viral RNA should obey the first 48 nucleotides of the positive-strand 3* end. In a
previous work, such a replacement in the E307-RNA re-rule of six (Fig. 1, E307-MCS series). When the E307-
MCS RNAs produced from these plasmids were tested sulted in an RNA derivative, GP48-RNA, that acquired the
replication ability of a copy back DI RNA (i.e., increasedfor their ability to replicate in the system outlined above,
the one RNA in the series whose total nucleotides was by 20-fold), and nevertheless, conserved its ability to tran-
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FIG. 1. Subgenomic SeVDI RNA structures and their derived vectors. The RNAs are depicted as 3* to 5* minus strand, with above, the positions
of relevant nucleotides as found in the full-length genomic RNA, and below, the positions of relevant restriction sites found on the double-stranded
DNA version. For the CBDI-H4-RNA: the 3* end portion of 110 nucleotides (IR) represents the complement of its 5* end from nucleotide 15,584 to
15,274. For DIDEL-E307-RNA: le/, leader plus RNA template; UAC, position of the N protein initiator codon; NP and L, the portions of the N and L
genes fused in the E307-RNA (11). le0, leader minus RNA template. For the SVec derivatives: MCS, multicloning site series with addition of 1, 2,
3, 4, and 5 nucleotides as depicted schematically for E307-MCS (see Materials and Methods).
scribe (Calain and Roux, 1995, see Introduction). The duced into a SeV-mixed virus stock (pvHAMCB119)
where a subgenomic RNA reacting with an M-specificSvec-CB119 series (Fig. 1) containing this feature was
therefore prepared. When compared to the RNA from the probe was detected after the first egg passage (Fig. 3B,
lane 3).SVecBsDr series, SVec-119 was found to replicate at
about the same level (Fig. 2B, Table 1), suggesting that Interestingly, the ratio of HA-M-CB119 to ND RNA in-
creased upon further passage in eggs (lanes 3, 4, andthe addition of nucleotides 73 to 119 of the N gene un-
translated region had no drastic effect on replication. On 5), a finding that demonstrated the stability of this sub-
genomic RNA, as well as its ability to interfere with thethe other hand, the copy back feature introduced into
SVec-CB119 resulted in a 4-fold increase in replication replication of the ND RNA helper. Fig. 3B (lane 2) shows
that a positive signal was detected in the virus stockefficiency. After insertion of the HA-M gene, HA-M-
CB119/0 replicated about 50- to 100-fold better than HA- recovered from a replication assay performed in the ab-
sence of the viral polymerase (0L). This was due to theM-BsKp and HA-M-BsDr (Fig. 3A), approaching the repli-
cation efficiency of the natural copy back DI H4 RNA subsequent amplification by the SeV ND, prior injection
into the eggs, of the residual T7 transcript encapsidated(Table 1). This HA-M-CB119/0 RNA was therefore intro-
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TABLE 1 HA-M was found to be functional in that it budded into
virus particles as efficiently as the endogenous M (seeSummary of the Subgenomic RNA Properties
below).
Total Replication Replication in
RNAa nucleotideb from DNAc SeV Stockd SeV M protein deletion mutants and their binding to
cellular membrane fractions
H4 1410 100 ////
E307 1.794 5 / The ability to quantitatively express a modified version
E307-MCS 1833–1838 of the SeV M protein in the pure context of the SeV
1836e 5 ND infection opened the way to structure–function analysis.
SVec-Bskp 0-5 214–219
This approach was indeed hampered before by an insuf-216e 1 0
ficient protein expression or by a deleterious effect onSVec-BsDr 0-5 282–287
282e 5 0 the SeV budding process of the only efficient enough
HA-M-BsDr 0-5 1500–1500 expression system available, i.e., vTF7-3 based system
1500e 0.3 0 (unpublished).
HA-M-BsKp 0-5 1432–1437
In an attempt to identify SeV M putative domains rele-1434e 0.3 0





a Types of RNAs as presented schematically in Fig. 1.
b For the series the numbers refer to the six RNAs whose length is
comprised in between the two given numbers.
c Efficiency of replication from cDNA refers to a comparison of the
relative replication efficiency where H4-RNA has been set at 100. The
numbers refer to experiments previously published (Calain and Roux,
1995), unpublished experiments, or experiments shown here. They rep-
resent an estimate whenever a strict comparison was not possible due
to differences in RNA size and probe. For instance when the HA-M-
BsKp and HA-M-BsDr were compared to E307, a riboprobe 10-fold
longer for the two former ones gave signals 2- to 3-fold lower than the
probe (of equivalent specific radioactivity) revealing E307.
d Replication in mixed SeV stocks refers to the ability to obtain (/)
or not (0) a mixed virus stock containing the subgenomic RNA. The
number of (/) is an indication of the relative efficiency with which the
subgenomic RNA replicates in cells inoculated with the viral stock. ND,
not done.
e The number refers to the size of the only one RNA in the series
that was found to replicate above background (see examples in Fig. 2).
during the initial transfection, reflecting the solidity of
HA-M-CB119 replication.
In cells infected with the pvHAMCB119 stocks, two
additional proteins, with apparent molecular weight
slightly larger than the viral M1 and M2 proteins, were
FIG. 2. Basic vector replication. Northern blot analysis of (A) the
detected. These proteins, present at levels similar to SVecBsKp and SVecBsDr 0RNAs series encapsidated and replicated
those of the other viral proteins, were immunoprecipi- when expressed from plasmid. The T7 RNA polymerase transcripts of
positive polarity were encapsidated and replicated by the N, P, and Ltated with anti-M and anti-HA monoclonal antibodies
proteins as described under Materials and Methods. The numbers(HA-M1 and HA-M2, Fig. 4, lanes 5 and 6). As M1 and M2
correspond to the individual RNAs in the series.//0 L refers to replica-represent two forms of M which differ by phosphorylation
tion assays performed in the presence or absence of the SeV L protein.
(described before as, respectively, B and M proteins, Mks, RNA markers of negative polarity made in vitro by the SP6 RNA
Lamb and Choppin, 1977), it is likely that HA-M1 and polymerase from, respectively, plasmids SVecBsDr0 and SVecBsKp0,
linearized at the HindIII site in the MCS. These markers roughly corre-HA-M2 also correspond to these two forms. This would
spond in size with the T7 RNA transcripts of their respective series.suggest that the HA tag did not alter the M protein struc-
(B) Comparison by Northern blot analysis of the replication efficiencyture so as to prevent its phosphorylation. The conserva-
of three basic vectors as described in the legend of Fig. 1. Only the
tion of a native structure was also supported by the reac- RNAs which obey the rule of six are presented. Mk, RNA marker of
tivity of HA-M for various M-specific monoclonal antibod- negative polarity from SVecBskp as in (A). The probe used for both
panels is a 32P-MCS oligonucleotide of positive polarity.ies (Fig. 4, for 383 and for two others, not shown). Finally,
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shown). Under conditions where more than 50% of the
wild-type M was reproducibly found associated with
membranes, the deletion of the last 48 amino acids
(dc48) as well as that of internal amino acids around
positions 90 to 130 (d31) reduced membrane binding to,
respectively, 6 and 8% (not shown).
Modification of a putative amphiphilic helix present in
a conserved region of the M protein
These two regions were examined in more detail. Al-
though the C-terminal portion had been proposed to par-
ticipate in the binding to membrane (Galinski et al., 1987),
no particular pattern in the last 40 amino acids was indic-
ative of an experimental approach to verify this hypothe-
sis. Two more deletion mutants were then prepared
missing, respectively, amino acids 308 through 327 or
326 through 348. When tested for their membrane associ-
ation, these two mutants unexpectedly exhibited the
binding properties of the wild-type protein (not shown).
In absence of any tertiary structure, the solving of this
paradox appeared seriously compromised and no further
work was undertaken concerning this region of the pro-
tein.
The deleted region in d31 (aa 106–136) appeared
FIG. 3. Replication efficiency of the HA-M copy back RNA vector and
more promising for further experimentation. It containsits introduction into a mixed virus stock. (A) Northern blot analysis of
HA-M-CB119/0 replication in comparison to the two noncopy back vec-
tors carrying the HA-M gene (see text of Results). //0 L as described
in the legend of Fig. 2. (B) Northern blot analysis of nucleocapsid RNAs
present in BHK cells infected with the ND SeV (lane 1) or with the
mixed virus stocks pvHAMCB119 (lanes 2–5). Lane 2, pvHAMCB119
stock obtained after one passage in eggs starting from a (0L) replica-
tion assay; lane 3, as in lane 2 but with a (/L) replication assay; lanes
4 and 5, pvHAMCB119 stocks representing, respectively, a second and
third egg passage of pvHAMCB119 presented in lane 3 (see Materials
and Methods). MK, in vitro made SP6 transcript of negative polarity
synthesized by from HA-M-pGem4. Probe for both panels, In vitro made
T7 32P-M transcript of positive polarity synthesized from M-pGem4.
vant for virus particle assembly and budding, a series of
deletion mutants were first prepared. The deletions were
generated using convenient restriction sites and resulted
in N-terminal (dn), internal (d), and C-terminal (dc)-trun-
cated proteins (Fig. 5). The majority of the proteins con-
tained only original M protein primary sequence, but a
few ended with one or more extra amino acids, gener-
ated by the addition or subtraction of a nucleotide intro-
duced to create a premature downstream stop codon
(see dc148, dc78, and dc142). The deleted proteins, pre-
FIG. 4. Production of the HA-M protein by the mixed virus stockspared in pGem4 vectors under the control of the T7 RNA
containing the HA-M-CB119/0 RNA. BHK cells (107) were infected with
polymerase promoter, were all transiently expressed and a ND SeV stock (lanes 1 to 3) or with the mixed virus stock
detected with a rabbit serum raised against the dena- pvHAMCB119 (lanes 4 to 6). After labeling with [35S]methionine and
cysteine as described under Materials and Methods, the cytoplasmictured (SDS-treated) M protein (not shown).
extracts were immunoprecipitated with a rabbit antiserum raisedIn a previous study, using flotation sucrose gradients,
against purified SeV virus (RAb-vir, lanes 1 and 4), with the anti Mthe SeV M protein expressed by itself was shown to
monoclonal antibody (lanes 2 and 5), or with the anti-HA epitope mono-
specifically bind to cellular membrane fractions (Stricker clonal antibody (lanes 3 and 6). L, P, HN, F0, NP, M1, and M2, the
et al., 1994). When analyzed by this same method, the structural SeV proteins; HA-M1 and HA-M2, the two forms of the tagged
M protein.deleted M proteins showed differential binding (not
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FIG. 5. Schematic representation of the deletion mutants of M protein. The proteins are presented with the N terminus to the left. The numbers
above the internal deletions refer to the borders of the deletions. For the C-terminally truncated proteins, the first number refers to the last M amino
acid with the mention of the added out of frame extra amino acids (dark box) when present. The total size of the proteins is given to the right.
the most conserved run of amino acids among at least mutant lysine-glutamic acid, with positive and negative
charges, showed no apparent change in the membraneseven members of the Paramyxoviridae family (see
Peeples, 1991). One of the four predicted membrane- binding property (5; Fig. 7). These results are summarized
in Table 2, which also shows the binding ability of theassociated helices (according to program HELIXMEM,
PC/GENE, IntelliGenetics Inc.) falls into this region and deletion mutant d31 analyzed in parallel with the site-
directed mutants.finally, when drawn as an helical wheel, the region of aa
104–119 forms one of the best possible amphiphilic helix
in the whole molecule (Fig. 6). Positive and/or negative Expression of the M protein mutants in SeV mixed
charges were then introduced by site-directed mutagen- virus infections
esis in the predicted hydrophobic face of the putative
helix, replacing the threonine 112 and the valine 113 with, To appreciate the possible consequences of the al-
tered membrane association of the M mutants on therespectively, lysine or arginine and glutamic acid, as well
introducing methionine at position 112, this in simple or assembly and budding of SeV, the site-directed M protein
mutants were tagged with the HA epitope and inserteddouble mutants (see Table 2).
The ability of these point mutants to associate with in the SeVCB119 vector as described above (also see
Methods). SeV-mixed virus stocks were then readily ob-membrane fractions in flotation gradient was next fol-
lowed when the proteins were expressed alone in a tained which directed quantitative expression of M mu-
tants 5, 11, 21, and 30 in infected cells. The intracellularvTF7-3 driven system. As before, about half of the wild-
type M was found in the top fractions (Fig. 7). The substi- (IC) M proteins, the budding efficiency, as well as the M
protein composition of the virus particles (VP) were thentution of the valine 113 with a glutamic acid, resulting in
the addition of a negative charge (mutant 11), reduced followed by Western blotting after infection with these
different mixed virus stocks (Fig. 8). For reference, a NDmembrane association by more than 20%. This was con-
firmed with mutant 30 (see Table 2), a double mutant SeV infection as well as a mixed virus infection express-
ing the wild-type HA-M (HA-Mwt) were analyzed in paral-where, along with the substitution of valine 113 with glu-
tamic acid, the threonine 112 was also replaced by methi- lel. The left panels of Fig. 8 show the characterization
of the M proteins detected with a monoclonal antibodyonine. In contrast, the introduction of a positive charge
by substitution of threonine 112 with lysine or arginine reacting with both the tagged and the untagged M. A
monoclonal antibody reacting with N was also presentrather increased membrane binding by about 15% (21,
47; Fig. 7 and Table 2). On the other hand, the double in the assay. The upper left panel shows that, in the
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FIG. 6. Helical wheel representation of the M protein 104–119 aa
segment. The segment of the protein deleted in d31 (aa 105–137) was
drawn as successive helical wheels of 15 aa long by the HELWHEEL
program of PC/GENE (IntelliGenetics Inc.). The stretch of 15 amino
acids 104–119, which comprises part of the most conserved region
(aa 110–124) of the M protein among seven members of the Paramyxo-
viridae (Peeples, 1991) exhibited the highest hydrophobic moment
(Eisenberg et al., 1982) of all the theoretical helices in the region. The
charged residues, shown in bold characters (five positive and one
FIG. 7. Membrane association of M protein mutants with substitu-negative charges), are all located on one face of the helix. The boxed
tions at positions 112 and 113. Five micrograms of the pGem plasmidsthreonine 112 and valine 113 are the two residues where the various
carrying wild-type or mutant M protein sequences were transfected insubstitutions were made, indicated by the aa pointing to the box (see
BHK cells infected with vTF7-3 (see Materials and Methods). Twenty-Materials and Methods and Table 2).
four hours later, the cells were harvested and the cytoplasmic extracts
were analyzed by flotation sucrose gradients (see Materials and Meth-
mixed virus-infected cells, a protein, seen as a unique ods). The collected fractions were TCA precipitated, resuspended in
SDS–PAGE sample buffer, and analyzed by Western blotting using theor as a doublet band, is detected above the doublet band
anti-M monoclonal antibody 383 to reveal the blot. The fluorographedrepresenting the wild-type M protein, identified as the
film was then scanned in a densitometer (Molecular Dynamics) toprotein present in the ND virus-infected cells (ND lane).
estimate the amount of M protein in each fraction.
In all the mixed virus-infected cells, with the exception
of the HA-Mwt sample (lane wt), this (or these) band(s)
is prominent over the M band. That these upper bands
represent the HA-M proteins was confirmed by their de-TABLE 2
tection with the anti-HA monoclonal antibody (Fig. 8, up-
Membrane Association Properties of the Mutated M Proteins
per right panel). Note here that no M band is detected
in the ND lane. Note as well that the HA-M 5, 11, andMembrane
Protein aaa 112–113 Chargesb Freec (%) boundc (%) 30 are visible as unique bands while HA-Mwt and 21 are
present as doublet confirming the pattern observed with
wt Thr-Val 0/0 49 46 the anti-M monoclonal antibody (upper left panel). The
5 Lys-Glu //0 46 47
N and M proteins present in virus particles produced are11 Thr-Glu 0/0 67 25
shown in the lower panels (VP). Two observations are21 Lys-Val //0 35 60
30 Met-Glu 0/0 70 20 noteworthy here. First, the M protein band is by far the
47 Arg-Val //0 30 60 predominant one in VP produced by the mixed virus-
d31 — — 47 29 infected cells, with the exception of sample 21 and HA-
Mwt. In fact the HA-M 5, 11, and 30 are absent in theNote. The wt M, the deletion mutant d31, and the M proteins mutated
virus particles as shown in the lower right panel revealedat positions 112 and/or 113 were individually expressed in cells from
pGem-4 plasmids in the context of vaccinia virus vTF7-3. Their ability with the anti-HA antibody. Second, the amounts of the
to bind to membrane fractions was tested by flotation gradients as M proteins (M or M plus HA-M) varies in the different
described in the legend of Fig. 7. samples, from high in ND, 21, and HA-Mwt to low ora Substitutions at position 112 and/or 113.
almost undetectable in 5 and 30. These variations paral-b Charges introduced in the protein at the point of substitution.
lel those of the N proteins in the VP samples, in condi-c Percentage of the protein found in the four bottom fractions (free)
and in the four top fractions (membrane bound). tions where the intracellular amounts of N (upper panels)
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sults confirm the observations from earlier studies,
where the same replacement, in the context of the natural
DI E307-RNA, was sufficient to confer high replication
efficiency (GP48; Calain and Roux, 1995). The mecha-
nism underlying such a remarkable effect is still unclear.
As the high replication is seen when the genomic pro-
moter is partially turned into an antigenomic promoter
over the first 48 nucleotides, this would suggest that the
higher strength postulated for the antigenomic promoter
(Simonsen et al., 1979; Soria et al., 1974; Schincariol and
Howatson, 1972; Kolakofsky and Bruschi, 1975) is entirely
confined to the first 48 nucleotides. Alternatively, the re-
placement of the genomic sequence with the antigeno-
mic one could allow base pairing between the RNA 3*
and 5* ends over 48 nucleotides, promoting (through a
FIG. 8. Effects of the expression of the M protein mutants during mechanism that remains unclear) an increase in RNA
SeV infection. BHk cell samples (107 cells) were infected at high multi-
replication. Although there is presently no evidence forplicity of infection (m.o.i.  10– 30) with either a ND SeV stock or with
the formation of such a structure in the nucleocapsid,the SeV mixed virus stocks expressing the wild-type or the mutant
HA-M proteins as indicated. Forty hours postinfection, the cells were this possibility was recently proposed by Wertz and col-
harvested and the cytoplasmic extracts were prepared as for nucleo- leagues (1994) to account for the high replication effi-
capsid RNA analysis. The cell supernatants were clarified, and the ciency of a VSV copy back RNA (le47), in which the in-
virus particles, pelleted through glycerol, were resuspended in SDS–
verted repeat was composed of only a genomic promoterPAGE sample buffer. Aliquots (1/200th) of the cytoplasmic extracts (IC
primary sequence. Future work will clearly be needed tosamples) and aliquots (1/10th) of the virus particles (VP samples) were
analyzed by Western blotting using anti-N, anti-M, and anti-HA mono- settle this point.
clonal antibodies as indicated. The copy back vector with its inserted gene contains
all the primary sequence features necessary for efficient
genome replication, transcription, and assembly into vi-are quite similar. For example, the intracellular N protein
rus particles. In addition, it interferes with the amplifica-amount in sample 30 is equivalent if not higher than that
tion of the ND RNA helper (see Fig. 3B). This seems toof sample 21, yet in the VP sample 30, the N protein is
exclude the requirement for cis-acting elements otherreduced by more than 10- to 15-fold compared to 21. As
than the 119 nucleotides at the 3* end and 171 at the 5*there is no reason for a change in the N protein composi-
tion of the nucleocapsid, the decrease in the fraction of
N taken up in virus particles must reflect a decrease in
nucleocapsid budding and presumably in virus particle
budding. This restriction in budding is better illustrated
in Fig. 9, where the fraction of the N protein produced in
VP is outlined for the different infections. There is a good
correlation between the absence of the HA-M proteins
in the virus particles and a reduction of virus particle
budding, suggesting that the M mutants that are not
taken up in virus particles can interfere with the budding
process. The three mutants (5, 11, and 30) that exhibit
that property have substituted a glutamic acid for valine
113, showing that this substitution is not allowed, possi-
bly because of the negative charge introduced at that
position.
DISCUSSION
FIG. 9. Estimation of virus particle production in the context of the
The first goal of this study was to obtain a SeV vector M protein mutant expression. The amounts of intracellular N protein
and of the N protein recovered in virus particles as shown in thecapable of expressing a protein at high level, in the only
Western blots of Fig. 9 (respectively, IC and VP samples) were esti-context of SeV infection. This was achieved through the
mated by densitometer scanning (Molecular Dynamics) of the fluoro-design of an RNA vector with copy back RNA feature
graphed films. The fractions of the N protein recovered in virus particles
created by the replacement of the first 48 nucleotides of were then calculated after correction for the difference in the size of
the genomic promoter with the corresponding nucleo- the aliquots (see legend to Fig. 8): NVP values, NVP measured values
120.tides coming from the antigenomic promoter. These re-
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end. These limits agree with previous results showing membrane association, as measured in flotation gradi-
ent, appears as a necessary but not sufficient propertythat the CAT gene flanked with 119 and 145 nucleotides
of, respectively, the genomic and the antigenomic 3* to participate in virus particle production. This is not sur-
prising in view of the other contacts that the M proteinends was expressed, although at much lower levels,
since only the enzymatic activity could be detected at has to make with the other viral partners (nucleocapsid,
viral glycoproteins). For instance HA-M 5, bound to mem-the exclusion of the template and the messenger RNAs
(Park et al., 1991). On the other hand, the replication of brane, could fail to interact with the nucleocapsid. Alter-
natively, its membrane association may have been weak-E307-MCS and of SVec-BsKp and SVec-BsDr-RNAs was
successful in the transfected cell system with only the ened by the mutations, as in the case of a N-terminally
truncated M protein of VSV (Chong and Rose, 1994). Thefirst 72 nucleotides of the genomic promoter flanked by a
polycloning site of 42 nucleotides. The recovery of these three HA-M mutants not incorporated into virus particles
(5, 11, and 30) were visible as single bands on PAGERNAs in mixed SeV virus stocks could, however, not be
achieved, possibly indicating a requirement for further (see Fig. 8, and unambiguous unpublished results), in
contrast to the wild-type M and the two other HA-M (wtsequence to increase the replication efficiency. A more
refined characterization of the 3*/5* end sequences and 21) seen as a doublet. As the single band coincides
with the upper band shown to correspond to the phos-within the limits determined in these previous studies is
currently under way. phorylated form of M (Lamb and Choppin, 1977), it is
tempting to speculate that the mutations in HA-M 5, 11,The stability of the subgenomic RNA carrying a redun-
dant function during virus passage is also an important and 30 promote their more efficient phosphorylation, ex-
plaining their absence in virus particle. The preferentialparameter in terms of the development of an expression
vector. When recombinant influenza viruses were pro- uptake of the nonphosphorylated form of M in virus parti-
cles had indeed been reported before (Lamb and Chop-duced carrying extra genomic RNA segments expressing
nonessential functions, these segments were lost, un- pin, 1977).
At this point, it would be hazardous and incorrect toless the nonessential gene was introduced into the es-
sential NA segment (Garcia-Sastre et al., 1994; Percy et conclude that a structure directly involved in membrane
binding has been identified in this study. It is neverthe-al., 1994). In the present case, it is likely that the copy-
back nature of the subgenomic RNA in itself represents less difficult to ignore the fact that the predicted theoreti-
cal helix 104–119 exhibits some properties coherent witha selective advantage, regardless of the relevance of the
encoded gene. Recently, an infectious SeV was produced such a structure, as well as are coherent the properties
induced by the mutations. This helix is positioned in onewhich contained a full-length RNA genome turned into a
copy back RNA by the replacement of the first 42 nucleo- of the most highly conserved region of M among seven
Paramyxoviruses (Peeples, 1991), suggesting that ittides of the genomic promoter with those of the antigeno-
mic promoter (rSVec-GP42). rSVec-GP42 out-competed could fulfill a function conserved among these viruses.
With a predicted mean hydrophobicity »H… of 00.41 andthe wild-type ND genome during coinfection in em-
bryonated eggs, supporting the replicative advantage a hydrophobic moment »mH… of 0.56, the helix falls into
the category of the ‘‘surface seeking helices’’ as definedprovided by the copy back feature (Garcin et al., 1995).
The cloning of the tagged M protein gene in the copy by Eisenberg et al. (1982). If such a helix would be partly
embedded in the membrane through its hydrophobicback SeV vector and the observation of its successful
expression from SeV-mixed virus infections opened the face, its hydrophilic face would rather be positively
charged so to make contact with the negatively chargedpossibility to perform M protein structure/function analy-
sis. The insertion of the charged amino acids in the theo- membrane inner surface. It is noteworthy that five of the
six charges in helix 104–119 are positive. The introduc-retical amphiphilic helix spanning amino acids 104 to
119 has undoubtedly produced interesting mutants. A tion of a negative charge in the helix hydrophobic face,
as in mutants 5, 11, and 30, would then favor chargeglutamic acid at position 113, introducing a negative
charge on the hydrophobic side of the helix, consistently repulsion between helix and membrane surface before
it would impede embedding. These comments remainprevented HA-M incorporation into virus particle, as well
as it decreased virus particle production (mutants 5, 11, highly speculative and should be backed up by future
experimental work.and 30). This effect did not necessarily correlate with
decreased membrane association, since HA-M 5 (with a What remains from this study is the demonstration that
a SeV vector with copy back feature has been shown//0 charge) exhibited a normal binding ability in contrast
to HA-M 11 and HA-M 30. It is noteworthy that HA-M 5, suitable to generate mutants of M protein which interfere
with viral assembly. Since the mutated proteins arein contrast to the two other mutants, acquired a positive
charge at position 112 as well. The introduction of only readily distinguishable from the endogenous wild-type
M, their fate can be followed easily in order to identifythis positive charge (mutant 21) appeared to confer better
membrane association, higher HA-M incorporation into the steps in viral assembly and budding at which the
interference takes place. Experiments are under way tovirus particle, and increased virus production. Therefore
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responsive adenyl cyclase complex from Saccharomyces cerevisiaecharacterize in more detail each of these mutants. The
by use of an epitope addition method. Mol. Cell. Biol. 8, 2159–2165.same approach can, in principle, be used for character-
Fuerst, T. R., Niles, E. G., Studier, F. W., and Moss, B. (1986). Eukaryoticization of any other viral protein, and can of course be transient-expression system based on recombinant vaccinia virus
extended to complementation studies. Efficient expres- that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad.
sion of cellular genes potentially important in the course Sci. USA 83, 8122–8126.
Galinski, M. S., Mink, M. A., Lambert, D. M., Wechsler, S. L., and Pons,of the viral infection or of any gene is also possible using
M. W. (1987). Molecular cloning and sequence analysis of the humanthis system. How prone to mutation the inserted gene
parainfluenza 3 virus gene encoding the matrix protein. Virology 157,will be in this system is of concern here, and this will
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